Single-Cell Transcriptomic Identification of Drug Repurposing Candidates for White Adipose Tissue Browning via scVI Embedding and LINCS L1000 Matching
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Preprint companion to a provisional patent application reporting computational identification of drug repurposing candidates for white adipose tissue (WAT) browning. Single-cell RNA sequencing data from GEO dataset GSE176171 (human adipose tissue atlas, 137,684 total cells, visceral and subcutaneous depots) was processed through quality control (45,201 cells retained), scVI variational autoencoder embedding (n_latent=30), and Leiden clustering (26 clusters). Nine target clusters corresponding to fat cells (n=9,060) and macrophages (n=6,052) were identified. Wilcoxon rank-sum differential expression analysis yielded 27,333 significant DE genes. Enrichr matching against LINCS L1000 Consensus Chemical Perturbation Signatures identified 4,700 drug repurposing candidates. Top candidates include camptothecin, MG-132, GW-5074, wortmannin, and BMS-754807. Five cross-disease signals — WZ-3105 (SRC/ABL), QL-XII-47 (MELK/FLT3), R-547 (CDK), SAR405838 (MDM2), and KPT-330/selinexor (XPO1) — were identified as consistent candidates across 5–20 independent disease scRNA-seq analyses in this portfolio.
Fields of Study & Subjects
Adipose Tissue and Metabolism
Single-cell and spatial transcriptomics
Computational Drug Discovery Methods
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 March 2026
- Language
- EN
- Document type
- Preprint